Profound Medical Correlations
| PROF Stock | USD 6.82 0.24 3.40% |
The current 90-days correlation between Profound Medical Corp and TriSalus Life Sciences is 0.39 (i.e., Weak diversification). The correlation of Profound Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Profound Medical Correlation With Market
Very poor diversification
The correlation between Profound Medical Corp and DJI is 0.84 (i.e., Very poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Profound Medical Corp and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Profound Stock
| 0.87 | QIPT | Quipt Home Medical Earnings Call This Week | PairCorr |
| 0.77 | VMD | Viemed Healthcare | PairCorr |
| 0.88 | 4DX | 4DMEDICAL | PairCorr |
| 0.96 | PRN | Profound Medical Corp | PairCorr |
| 0.68 | PINK | Perimeter Medical Imaging | PairCorr |
| 0.95 | AFW | Align Technology | PairCorr |
Moving against Profound Stock
| 0.93 | IHC | Inspiration Healthcare | PairCorr |
| 0.82 | OTC | Ocumetics Technology Corp | PairCorr |
| 0.78 | IVF | INVO Fertility Symbol Change | PairCorr |
| 0.73 | AHC | Austco Healthcare | PairCorr |
| 0.68 | NTI | Neurotech International | PairCorr |
| 0.51 | RHT | Resonance Health | PairCorr |
| 0.42 | AHG | Akso Health Group | PairCorr |
| 0.75 | NGMD | NuGen Medical Devices | PairCorr |
| 0.64 | TNONW | Tenon Medical Warrant | PairCorr |
| 0.6 | MLSS | Milestone Scientific | PairCorr |
| 0.6 | NVNO | enVVeno Medical Corp | PairCorr |
| 0.51 | NSPR | InspireMD | PairCorr |
| 0.32 | MODD | Modular Medical | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Profound Stock performing well and Profound Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Profound Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TLSI | 3.25 | 0.11 | 0.02 | 0.18 | 4.16 | 8.30 | 25.94 | |||
| MXCT | 3.17 | (0.85) | 0.00 | (0.47) | 0.00 | 5.44 | 16.52 | |||
| CATX | 5.25 | 1.32 | 0.21 | 0.84 | 5.01 | 8.14 | 77.44 | |||
| LNSR | 1.73 | 0.01 | 0.00 | 0.06 | 2.56 | 3.50 | 11.85 | |||
| AVR | 3.77 | 0.52 | 0.15 | 1.11 | 3.15 | 9.42 | 25.09 | |||
| NNOX | 3.78 | (0.54) | 0.00 | (0.39) | 0.00 | 9.44 | 36.87 | |||
| PRE | 3.75 | 0.47 | 0.11 | 0.35 | 3.87 | 8.75 | 22.19 | |||
| STIM | 5.38 | (0.78) | 0.00 | (0.20) | 0.00 | 10.55 | 28.95 | |||
| OWLT | 4.01 | 0.40 | 0.07 | 25.45 | 4.91 | 8.21 | 24.32 | |||
| ARMP | 5.30 | 0.89 | 0.14 | 0.50 | 5.83 | 14.73 | 38.51 |
Profound Medical Corporate Management
| Arun MBA | Chairman CEO | Profile | |
| Hartmut Warnken | Senior Alliances | Profile | |
| Jacques Cornet | Senior Sonalleve | Profile | |
| Stephen Kilmer | Investor Relations | Profile | |
| Mathieu Burtnyk | Senior TULSAPRO | Profile | |
| Thomas MBA | Chief Officer | Profile | |
| Abbey Goodman | Chief Global | Profile |